Omeros Corporation

NASDAQ:OMER

Biotechnology

Healthcare
$14.55 +4.46%

+$0.43 today

Market cap
$1.08B
Beta
2.53
P/E (TTM)
8.4
EPS (TTM)
$1.20
52W Low $2.95High $17.65

Volume 2.53M

Average 1.55M

OMER Pre-Tax Margin

Income before tax as a percentage of revenue.

Omeros CorporationNASDAQ: OMER

Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026

Pre-tax margin at 518.6%

Pre-tax margin was 518.6% in Q1 FY2026. On a trailing-twelve-month basis it was 870.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
518.6%— QoQ
Last fiscal yearDec 2025
—— YoY
LTMMar 2026
870.1%— YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3 years———
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

No Pre-Tax Margin data reported for this period type.

Pre-Tax Margin vs competitors

How OMER compares with its peers on the latest reported figures

  • OMER's LTM Mar 2026 pre-tax margin of 870.1% is the highest of the 8 companies compared; the peer median is -153.2%.
OMER Competitors Peer median
Pre-Tax Margin for OMER and competitors
Company Period LTM level YoY 3-year change
OMEROmeros CorporationLTM Mar 2026870.1% ——
CGENCompugen Ltd.LTM Mar 202648.0% +82.8 pp+497.1 pp
ANABAnaptysBio, Inc.LTM Mar 2026-11.5% +114.2 pp+1245.5 pp
MGNXMacroGenics, Inc.LTM Mar 2026-45.2% -9.2 pp+29.5 pp
XNCRXencor, Inc.LTM Jun 2026-153.2% -43.9 pp-38.1 pp
NKTRNektar TherapeuticsLTM Jun 2026-287.1% -123.4 pp+99.2 pp
RCUSArcus Biosciences, Inc.LTM Jun 2026-386.3% -269.5 pp+94.6 pp
MREOMereo BioPharma Group plcLTM Mar 2026-7158.7% ——
BHVNBiohaven Ltd.FY2025— ——
CRVSCorvus Pharmaceuticals, Inc.FY2025— ——
CGEMCullinan Therapeutics, Inc.FY2025— ——
Peer median (excluding OMER) -153.2%-26.6 pp+96.9 pp

Competitors are the stored peer set for OMER. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue1.39M0000
Gross Profit(1.39M)0000
Gross Margin—————
Research & Development118.78M112.72M114.87M119.52M81.3M
Selling, General & Admin53.46M50.67M49.66M49.74M41.5M
Operating Expenses172.23M163.39M164.53M169.26M122.8M
Depreciation & Amortization1.39M952K920K950K964K
EBITDA(170.49M)(158.38M)(143.16M)(157M)(1.83M)
EBITDA Margin—————
Operating Income(173.62M)(163.39M)(164.53M)(169.26M)(122.8M)
Operating Margin—————
Interest Income17.93K4.06M16.34M11.3M5.06M
Interest Expense19.67M22.7M30.84M24.68M0
Other Income / Expenses(17.93M)(18.64M)(10.39M)(13.37M)120M
Income Before Tax(191.55M)(182.03M)(174.92M)(182.63M)(2.8M)
Pre-Tax Margin—————
Income Tax Expense00002.01M
Net Income(111.41M)47.42M(117.81M)(156.82M)(3.35M)
Net Margin—————
EPS (Basic)3.120.46(1.88)(2.70)(0.05)
EPS (Diluted)3.120.46(1.88)(2.70)(0.05)
Weighted Avg Shares62.34M62.74M62.74M58.17M63.51M
Weighted Avg Shares (Diluted)62.34M62.74M62.74M58.17M63.51M

Omeros Corporation

NASDAQ:OMER

Intrinsic Alpha fair value

Locked

Current Price

$14.55

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.